José Cabrera

Paneth cell defects in Crohn’s disease patients promote dysbiosis

Ta‐Chiang Liu, Bhaskar Gurram, Megan T. Baldridge et al. · JCI Insight · 2016 · 129 citations · Full text

Life Sciences, Microbiology, Pediatrics +17

Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort

Maria Oliva‐Hemker, Susan Hutfless, Elie S. Al Kazzi et al. · The Journal of Pediatrics · 2015 · 103 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn’s Disease

Victoria Grossi, Trudy Lerer, Anne M. Griffiths et al. · Clinical Gastroenterology and Hepatology · 2015 · 101 citations · Full text

Medicine, Immunology, Pediatrics +17

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Moving On: Transition Readiness in Adolescents and Young Adults With IBD

Amitha Gumidyala, Rachel Neff Greenley, Jill M. Plevinsky et al. · Inflammatory Bowel Diseases · 2018 · 55 citations · Full text

Medicine, Pediatrics, Adolescent Development +16